WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 15-Jul-2014 (Data received as of 8-Jul-2014)
Next overall update Fall 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 9'8701 Infant (under 12 months) mortality rate: 82
GDP / capita (US$): 17'1701 Child (under 5 years) mortality rate: 92

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 4'822  4'647  4'478  4'341  4'247  3'235  2'703  2'605 
Births 64  62  60  57  56  62  68  78 
Surviving infants 63  61  59  57  55  61  66  75 
Pop. less than 5 years 302  281  269  273  276  305  311  366 
Pop. less than 15 years 1'004  1'003  1'009  1'029  1'041  927  923  1'017 
Female 15-49 years 1'372  1'303  1'232  1'168  1'132  885  688  626 

Number of reported case

(Click for retrospective incidence data for Lebanon)
Diphtheria
Japanese encephalitis
Measles 1'761  12  22 
Mumps 14  12  12  28  135  23 
Pertussis 58  53  19  65 
Polio*
Rubella 27  21 
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Lebanon)
Vaccine year result method % card seen                                                
BCG         
DTP1 2008  84  MICS   55  100  99  98  98  96  93 
DTP3 2008  72  MICS   55  98  95  95  94  93  90  82 
HepB_BD          100  94  99  98  96  90 
HepB3 2008  72  MICS   55  98  95  95  94  93  70 
Hib3 2008  72  MICS   55  98  95  95  94  93 
JapEnc         
MCV 2008  79  MICS   55  99  98  98  95  93  90  39 
MCV2          79  88  86  89  88  87 
PCV1         
PCV3         
Pol3 2008  74  MICS   55  100  96  96  94  93  90  82 
Rota1         
Rota_last         
Rubella1          99  98  98  95  93 
TT2plus         
PAB         
VAD1         
YFV 2003  50  PAPFAM   62 
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Lebanon)
DTP1 84  84  84  84  84  90  94  17 
DTP3 81  81  81  81  81  83  82 
HepB3 81  81  81  81  81  83 
HepB_BD 94  94  94  94  94  90 
Hib3 81  81  81  81  81 
MCV 79  79  79  79  79  71  61 
MCV2 75  75  75  75  75  56 
PCV3
Pol3 75  75  75  75  75  83  82 
Rota_last

Number of districts in the country 26  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90% 100
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
DTwP 4-5 years; Yes
DTwPHibHepB 2, 4, 6, 18 months;
HepB birth; Yes
IPV 2 months; Yes
Measles 9 months; Yes
MMR 1, 4-5 years; Yes
OPV 4, 6, 18 months; 4-5, 10-12 years; Yes
Td 10-12, 16-18 years; Yes

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2010-2014  2010-2014  2010-2014  2010-2014  2010- 2014  2009-2013  2007-2009 
Nº of districts with microplans that include activities to raise immunization coverage number 25  20  18  17  15  25 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes       

System performance

Total Nº districts in country number 26  26  26  26  26  26  25 
Nº districts with DTP3 coverage >=80% number 26  26  26  25  26 
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  100  96  100 
Nº districts with measles (MCV1) coverage >=95% number 20  18  11  12   
% of districts with MCV1 coverage >=95% From 0 to 100% 77  69  23  35  42  46   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100% 100  100    100  100  100  100 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.